Covered recipient · General Payments record
ERIC A SCHAFF
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2021
$660.69
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.07 | 10 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $40.28 | 2 |
| Neurelis, Inc. | $39.16 | 2 |
| GlaxoSmithKline, LLC. | $27.20 | 2 |
| Cranial Technologies, Inc | $25.37 | 1 |
| Merck Sharp & Dohme Corporation | $12.00 | 1 |
| Exeltis, USA Inc. | $11.60 | 1 |
| Mylan Pharmaceuticals Inc. | $11.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.86 | 04/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795977125 | CMS |
| AbbVie Inc. | $23.42 | 05/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795977129 | CMS |
| Cranial Technologies, Inc | $25.37 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 777824635 | CMS |
| Exeltis, USA Inc. | $11.60 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806202067 | CMS |
| GlaxoSmithKline, LLC. | $14.68 | 01/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802731635 | CMS |
| GlaxoSmithKline, LLC. | $12.52 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801681985 | CMS |
| Merck Sharp & Dohme Corporation | $12.00 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848489743 | CMS |
| Mylan Pharmaceuticals Inc. | $11.46 | 05/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965462087 | CMS |
| Neurelis, Inc. | $19.59 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 842878777 | CMS |
| Neurelis, Inc. | $19.57 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 842878781 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.